Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cpi 613
2. Cpi-613
3. Cpi613
4. Devimistat
1. Cpi-613
2. 95809-78-2
3. Devimistat
4. Cpi 613
5. 6,8-bis(benzylsulfanyl)octanoic Acid
6. Mls006010202
7. Cpi613
8. Schembl1062218
9. Mfcd22420826
10. E76113ir49
11. 6,8-bis[(phenylmethyl)thio]octanoic Acid
12. Octanoic Acid, 6,8-bis((phenylmethyl)thio)-
13. Octanoic Acid, 6,8-bis[(phenylmethyl)thio]-
14. Unii-e76113ir49
15. Devimistat [inn]
16. Devimistat [who-dd]
17. 6,8-bis(benzylthio)octanoicacid
18. Chembl3186849
19. Dtxsid70914807
20. Hms3656l06
21. Hms3873f13
22. 6,8-bis(benzylthio)-octanoic Acid
23. Bcp04663
24. Ex-a2043
25. Nsc766888
26. S2776
27. Akos025142095
28. Bcp9000552
29. Ccg-268505
30. Cs-0961
31. Db12109
32. Nsc-766888
33. Ncgc00344764-01
34. Ac-32929
35. As-16613
36. Hy-15453
37. Smr004701300
38. Sy234319
39. Bcp0726000030
40. 6,8-bis-benzylsulfanyl-octanoic Acid
41. Sw220297-1
42. (+/-)-6,8-bis(benzylthio)octanoic Acid
43. 6,8-bis(benzylthio)octanoic Acid, (+/-)-
44. J-518174
45. 6,8-bis(benzylthio)-octanoic Acid, >=98% (hplc)
46. Q27276958
47. Rac-(6r)-6,8-bis(benzylsulfanyl)octanoic Acid
| Molecular Weight | 388.6 g/mol |
|---|---|
| Molecular Formula | C22H28O2S2 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 13 |
| Exact Mass | 388.15307248 g/mol |
| Monoisotopic Mass | 388.15307248 g/mol |
| Topological Polar Surface Area | 87.9 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 363 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Devimistat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Devimistat, including repackagers and relabelers. The FDA regulates Devimistat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Devimistat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Devimistat supplier is an individual or a company that provides Devimistat active pharmaceutical ingredient (API) or Devimistat finished formulations upon request. The Devimistat suppliers may include Devimistat API manufacturers, exporters, distributors and traders.
Devimistat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Devimistat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Devimistat GMP manufacturer or Devimistat GMP API supplier for your needs.
A Devimistat CoA (Certificate of Analysis) is a formal document that attests to Devimistat's compliance with Devimistat specifications and serves as a tool for batch-level quality control.
Devimistat CoA mostly includes findings from lab analyses of a specific batch. For each Devimistat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Devimistat may be tested according to a variety of international standards, such as European Pharmacopoeia (Devimistat EP), Devimistat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Devimistat USP).
LOOKING FOR A SUPPLIER?
